ESC 365 - Sudden death risk assessment in hypertrophic cardiomyopathy should include myocardial fibrosis imaging: con

ESC Professional Premium Access

Sudden death risk assessment in hypertrophic cardiomyopathy should include myocardial fibrosis imaging: con

Session: Great Debate: assessing the risk of sudden death in hypertrophic cardiomyopathy should include myocardial fibrosis imaging

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor A. Kammerlander (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Andreas Kammerlander

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

3 presentations

1 follower

2 more presentations in this session

Sudden death risk assessment in hypertrophic cardiomyopathy should include myocardial fibrosis imaging: pro

Speaker: Doctor C. Kramer (Charlottesville, US)

Sudden death risk assessment in hypertrophic cardiomyopathy should include myocardial fibrosis imaging - discussion

Access the full session

Great Debate: assessing the risk of sudden death in hypertrophic cardiomyopathy should include myocardial fibrosis imaging

Speakers: Doctor A. Kammerlander, Doctor C. Kramer

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources